Tokyo Tape
Sign in
← GNI Group

Quarterly report · Q1

2160.TEDINET S100TFYV
Period2024-01-01 → 2024-03-31
Filed2024-05-15
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥5.9bn2024-01-01 → 2024-03-31Cons.Revenue IFRS
Revenue¥26.0bn2023-01-01 → 2023-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥4.2bn2023-01-01 → 2023-03-31Cons.Revenue IFRS
Operating income¥2.3bn2024-01-01 → 2024-03-31Cons.Operating profit loss IFRS
Operating income¥398m2023-01-01 → 2023-03-31Cons.Operating profit loss IFRS
Profit before tax¥1.8bn2024-01-01 → 2024-03-31Cons.Profit loss before tax IFRS
Profit before tax¥12.6bn2023-01-01 → 2023-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax−¥65m2023-01-01 → 2023-03-31Cons.Profit loss before tax IFRS
Net income (owners)¥1.5bn2024-01-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥8.1bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)−¥3m2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income¥1.3bn2024-01-01 → 2024-03-31Cons.Profit loss IFRS
Net income¥9.5bn2023-01-01 → 2023-12-31Cons.Profit loss IFRS (5-year summary)
Net income−¥342m2023-01-01 → 2023-03-31Cons.Profit loss IFRS
Total assets¥65.6bnat 2024-03-31Cons.Assets IFRS
Total assets¥62.4bnat 2023-12-31Cons.Assets IFRS
Total assets¥34.1bnat 2023-03-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥27.8bnat 2024-03-31Cons.Liabilities IFRS
Total liabilities¥26.3bnat 2023-12-31Cons.Liabilities IFRS
Net assets / equity¥37.8bnat 2024-03-31Cons.Equity IFRS
Net assets / equity¥36.1bnat 2023-12-31Cons.Equity IFRS
Net assets / equity¥19.8bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥19.8bnat 2022-12-31dCons.Equity IFRS
Equity (owners)¥34.6bnat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥33.8bnat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥21.2bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥20.3bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥21.6bnat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥10.6bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥11.0bnat 2022-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow−¥350m2024-01-01 → 2024-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥6.5bn2023-01-01 → 2023-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥710m2023-01-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥1.8bn2024-01-01 → 2024-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥6.8bn2023-01-01 → 2023-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥1.2bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥88m2024-01-01 → 2024-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥10.7bn2023-01-01 → 2023-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥52m2023-01-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥29.172024-01-01 → 2024-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥169.52023-01-01 → 2023-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥-0.062023-01-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (diluted)¥282024-01-01 → 2024-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥165.562023-01-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥-0.062023-01-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS
Equity ratio52.7%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio54.2%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio62.2%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 22
SegmentItemPeriodValue
jpcrp040300-q1r_E05712-000Medical Devicereportable segmentrevenue2024-01-01 → 2024-03-31¥1.3bn
jpcrp040300-q1r_E05712-000Medical Devicereportable segmentrevenue external2024-01-01 → 2024-03-31¥1.3bn
jpcrp040300-q1r_E05712-000Medical Devicereportable segmentsegment profit2024-01-01 → 2024-03-31¥539m
jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segmentrevenue2024-01-01 → 2024-03-31¥4.6bn
jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segmentrevenue external2024-01-01 → 2024-03-31¥4.6bn
jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segmentsegment profit2024-01-01 → 2024-03-31¥1.7bn
—segment totalrevenue2024-01-01 → 2024-03-31¥5.9bn
—segment totalrevenue external2024-01-01 → 2024-03-31¥5.9bn
—segment totalsegment profit2024-01-01 → 2024-03-31¥2.3bn
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-03-31−¥23m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-03-31−¥23m
jpcrp040300-q1r_E05712-000Medical Devicereportable segmentrevenue2023-01-01 → 2023-03-31¥623m
jpcrp040300-q1r_E05712-000Medical Devicereportable segmentrevenue external2023-01-01 → 2023-03-31¥600m
jpcrp040300-q1r_E05712-000Medical Devicereportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥23m
jpcrp040300-q1r_E05712-000Medical Devicereportable segmentsegment profit2023-01-01 → 2023-03-31¥248m
jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segmentrevenue2023-01-01 → 2023-03-31¥3.6bn
jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segmentrevenue external2023-01-01 → 2023-03-31¥3.6bn
jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segmentsegment profit2023-01-01 → 2023-03-31¥149m
—segment totalrevenue2023-01-01 → 2023-03-31¥4.2bn
—segment totalrevenue external2023-01-01 → 2023-03-31¥4.2bn
—segment totalrevenue intersegment2023-01-01 → 2023-03-31¥23m
—segment totalsegment profit2023-01-01 → 2023-03-31¥398m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 599
ItemContextValueUnit
Liabilities and equity IFRSCurrentQuarterInstant65600114000JPY
Revenue IFRSPrior1YTDDuration4206135000JPY
Revenue IFRSCurrentYTDDuration5948569000JPY
Cost of sales IFRSPrior1YTDDuration573357000JPY
Cost of sales IFRSCurrentYTDDuration1217077000JPY
Gross profit IFRSPrior1YTDDuration3632777000JPY
Gross profit IFRSCurrentYTDDuration4731491000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration2646363000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration3288379000JPY
Research and development expenditure recognized as expense during period IFRSPrior1YTDDuration635649000JPY
Research and development expenditure recognized as expense during period IFRSCurrentYTDDuration688911000JPY
Other income IFRSPrior1YTDDuration132214000JPY
Other income IFRSCurrentYTDDuration1786362000JPY
Other expenses IFRSPrior1YTDDuration85381000JPY
Other expenses IFRSCurrentYTDDuration256743000JPY
Operating profit loss IFRSPrior1YTDDuration397598000JPY
Operating profit loss IFRSCurrentYTDDuration2283819000JPY
Finance income IFRSPrior1YTDDuration49329000JPY
Finance income IFRSCurrentYTDDuration161678000JPY
Finance costs IFRSPrior1YTDDuration239599000JPY
Finance costs IFRSCurrentYTDDuration629737000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1YTDDuration-272262000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYTDDuration11412000JPY
Profit loss before tax IFRSPrior1YTDDuration-64934000JPY
Profit loss before tax IFRSCurrentYTDDuration1827172000JPY
Income tax expense IFRSPrior1YTDDuration276810000JPY
Income tax expense IFRSCurrentYTDDuration483010000JPY
Profit loss IFRSPrior1YTDDuration-341745000JPY
Profit loss IFRSCurrentYTDDuration1344162000JPY
Profit loss attributable to owners of parent IFRSPrior1YTDDuration-2874000JPY
Profit loss attributable to owners of parent IFRSCurrentYTDDuration1454508000JPY
Profit loss attributable to non controlling interests IFRSPrior1YTDDuration-338870000JPY
Profit loss attributable to non controlling interests IFRSCurrentYTDDuration-110345000JPY
Basic earnings loss per share IFRSPrior1YTDDuration-0.06
Basic earnings loss per share IFRSCurrentYTDDuration29.17
Diluted earnings loss per share IFRSPrior1YTDDuration-0.06
Diluted earnings loss per share IFRSCurrentYTDDuration28.00
Profit loss IFRSPrior1YTDDuration-341745000JPY
Profit loss IFRSCurrentYTDDuration1344162000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration282489000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration601052000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration2222000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration16431000JPY
Other comprehensive income IFRSPrior1YTDDuration284712000JPY
Other comprehensive income IFRSCurrentYTDDuration617483000JPY
Comprehensive income IFRSPrior1YTDDuration-57033000JPY
Comprehensive income IFRSCurrentYTDDuration1961646000JPY
Comprehensive income attributable to owners of parent IFRSPrior1YTDDuration203671000JPY
Comprehensive income attributable to owners of parent IFRSCurrentYTDDuration1945305000JPY
Comprehensive income attributable to non controlling interests IFRSPrior1YTDDuration-260704000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-12-31pass
balance sheet identityconsolidated 2024-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-03-31pass